Astrocytic alterations induced by HTLV type 1-infected T lymphocytes: A role for Tax-1 and tumor necrosis factor α

AIDS Research and Human Retroviruses

Volumn 16, Issue 16, 2000, Pages 1723-1729

  Szymocha, R ^a   Akaoka, H ^a   Brisson, C ^a   Beurton Marduel, P ^a   Chalon, A ^a   Bernard, A ^a   Didier Bazes, M ^a   Belin, M F ^a   Giraudon, P ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GLUTAMATE AMMONIA LIGASE; GLUTAMATE DEHYDROGENASE; GLUTAMATE TRANSPORTER; GLUTAMIC ACID; MATRIX METALLOPROTEINASE; METALLOPROTEINASE INHIBITOR; TAX PROTEIN; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL INTERACTION; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME REGULATION; GLIA CELL; GLIOSIS; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; T LYMPHOCYTE;

EID: 0034329303     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/08892220050193218     Document Type: Article

References (40)

1. Direct visualization of antigen-specific T cells: HTLV-1 Tax11-19-specific CD8(+) T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients
2. The dynamics of HTLV-I and the CTL response
3. Human T-lymphotropic virus type I-associated myelopathy and tax gene expression in CD4+ T lymphocytes
4. Detection of human T-lymphotropic virus type I p40tax protein in cerebrospinal fluid Cells from patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis
5. Extracellular Tax1 protein stimulates tumor necrosis factor-beta and immunoglobulin kappa light chain expression in lymphoid cells
6. Clinical and neuropathological study of six patients with spastic paraparesis associated with HTLV-I: An axomyelinic degeneration of the central nervous system
7. Metabolism and role of glutamate in mammalian brain
8. Long-term effects of HTLV-1 on brain astrocytes: Sustained expression of Tax-1 associated with synthesis of inflammatory mediators
9. T lymphocytes activated by persistent viral infection differentially modify the expression of metalloproteinases and their endogenous inhibitors, TIMPs, in human astrocytes: Relevance to HTLV-I-induced neurological disease
10. Induction of MMP9 (92 kDa gelatinase) activity and expression of tissue inhibitor of metalloproteinase-2 mRNA (TIMP-2) in primitive neuroectodermal cells infected with retrovirus HTLV-I
11. Retroviral infection (HTLV-I) induces cytokine-regulated immunomodulation and cytotoxicity of medulloblastoma cells
12. Detection of mRNA for the tax1/rex1 gene of human T-cell leukemia virus type I in fresh peripheral blood mononuclear cells of adult T-cell leukemia patients and viral carriers by using the polymerase chain reaction
13. Imbalanced expression of glutamate-glutamine cycle enzymes induced by human T-cell lymphotropic virus type 1 Tax protein in cultivated astrocytes
14. Cytokine induction in HTLV-I associated myelopathy and adult T-cell leukemia: Alternate molecular mechanisms underlying retroviral pathogenesis
15. Cytokine expression in the spinal cord lesions in HTLV-I-associated myelopathy
16. Molecular profile of reactive astrocytes - Implications for their role in neurologic disease
17. Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states
18. Extracellular matrix remodeling during morphogenesis
19. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates
20. Extracellular matrix-remodeling metalloproteinases and infection of the central nervous system with retrovirus human T-lymphotropic virus type I (HTLV-I)
21. Cytokines secreted by glial cells infected with HTLV-I modulate the expression of matric metalloproteinases (MMPs) and their natural inhibitor (TIMPs): Possible involvement in neurodegenerative processes
22. Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis
23. Tissue inhibitor of metalloproteinase TIMP-3, matrix metalloproteinase-9, and neopterin in the cerebrospinal fluid: Preferential presence in HTLV-1 infected neurologic patients versus healthy virus carriers
24. Matrix metalloproteinase 9 (gelatinase B) in cerebrospinal fluid of HTLV-1 infected patients with tropical spastic paraparesis
25. Expression of matric metalloproteinases and tissue inhibitors of metalloproteinases in HTLV-I-associated myelopathy
26. An autoaggressive process against bystander tissues in HTLV-I-infected individuals: A possible pathomechanism of HAM/TSP
27. Antibody titers to HTLV-I-p40tax protein and gag-env hybrid protein in HTLV-I-associated myelopathy/tropical spastic paraparesis: Correlation with increased HTLV-I proviral DNA load
28. In situ demonstration of the HTLV-I genome in the spinal cord of a patient with HTLV-I-associated myelopathy
29. Detection of human T-lymphotropic virus type I (HTLV-I) tax RNA in the central nervous system of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by in situ hybridization
30. Identification of human T-cell lymphotropic virus type I 21-base-pair repeat-specific and glial cell-specfic DNA-protein complexes
31. Astrocytes express elements of the class II endocytic pathway and process central nervous system autoantigen for presentation to encephalitogenic T cells
32. Astrocyte-specific expression of human T-cell lymphotropic virus type 1 (HTLV-1) Tax: Induction of tumor necrosis factor alpha and susceptibility to lysis by CD8+ HTLV-1-specific cytotoxic T cells
33. Accumulation of human T lymphotropic virus (HTLV)-I-specific T cell clones in HTLV-I-associated myelopathy/tropical spastic paraparesis patients
34. Tumor necrosis factor alpha inhibits glutamate uptake by primary human astrocytes. Implications for pathogenesis of HIV-1 dementia
35. Excitatory transmitter neurotoxicity
36. Vulnerability of oligodendroglia to glutamate: Pharmacology, mechanisms, and prevention
37. Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases?
38. Glutamate transport and metabolism in astrocytes
39. New insights into the compartmentation of glutamate and glutamine in cultured rat brain astrocytes
40. Energy metabolism